OneMedNet Reports Strong Momentum and Industry Excitement at RSNA
GlobeNewswire Inc.
17 minutes ago
MINNEAPOLIS, Dec. 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading curator and provider of one of the world's largest regulatory-grade, AI-ready Real-World Data (RWD) network, today announced significant engagement and
American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Fifth Pennsylvania Distributor – Ace Distributing – as American Rebel Light Beer’s Rapid Distribution Network Expansion Continues
GlobeNewswire Inc.
22 minutes ago
American Rebel Holdings Inc American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Fifth Pennsylvania Distributor – Ace Distributing – as American Rebel Light Beer’s Rapid Distribution Network Expansion Continues Ace Distributing, a 75-year-old t
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™
GlobeNewswire Inc.
30 minutes ago
Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic’s granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq
IQSTEL Announces 2025 Accomplishments and Strategic Priorities for 2026 in New Interview
GlobeNewswire Inc.
37 minutes ago
2025 Achievements Lay Foundation for Accelerated 2026 Expansion NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- IQSTEL Inc. (NASDAQ: IQST) ("IQSTEL"), a leading provider of innovative telecommunications and technology solutions, today announced highlig
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
GlobeNewswire Inc.
37 minutes ago
Clinical trial achieved all three primary objectives with no significant safety issues being reported Results indicate that Emrosi can be safely used for up to 16 weeks with no detectable impact on skin, GI tract or vaginal microbiota FDA-approved Em
Veru to Report Fiscal Year 2025 Financial Results on December 17th
GlobeNewswire Inc.
37 minutes ago
MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it wil
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
GlobeNewswire Inc.
37 minutes ago
THE WOODLANDS, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the publication of preclinical data validating Acyl-CoA Synthetase 5 (ACSL5) as a target for obesity and chronic weight management.
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
GlobeNewswire Inc.
37 minutes ago
Platform Poised to Expand into Joint and Cartilage RepairHOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending
Golden Rapture Increases Land Position at Its Newly Acquired Northern Queen Mine Property Adjacent to NexGold Mining & Dryden Gold Corp
Newsfile
37 minutes ago
Edmonton, Alberta--(Newsfile Corp. - December 10, 2025) - Golden Rapture Mining Corporation (CSE: GLDR) is pleased to announce that it has staked an additional 7 claim units at its 100% owned Northern Queen Mine property located southeast of Dryden,
Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds
GlobeNewswire Inc.
37 minutes ago
HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today annou